Health and longevity studies in C. elegans: the ‘‘healthy worm database’’ reveals strengths, weaknesses and gaps of test compound-based studies.
An overview of the use of C. elegans in longevity research including the genetic manipulation of animals.Download PDF
De-risking drug candidates ahead of rodent studies with a non-mammalian model for ageing, neurodegeneration and the microbiome using C. elegans.Download PDF
Magnitude Biosciences presentation from ELRIG online 2020 on the use of C. elegans in pre- clinical drug trials for ageing, neurodegeneration and microbiome.
How large scale non-invasive imaging of C. elegans to enable reliable measurement of Ageing, Neurodegeneration and Behaviour.
Microbiome SIG Webinar Series
Our CEO, Dr. David Weinkove, explains how healthspan readouts can be used to understand mechanisms in the microbiome.
Our CEO, David Weinkove, discusses the use of C. elegans and how they could be used in the field of Geroscience to accelerate the drug development process.
Chemosensory Neurons Modulate the Response to Oomycete Recognition in Caenorhabditis elegans
The Barkoulas Lab, including our own Michael Fasseas , find an Oomycetes recognition response in C. elegans which leads to a reduction in the attachment of pathogens with applications for immunity and animal survival.Download PDF
Neuronal SKN-1B modulates nutritional signalling pathways and mitochondrial networks to control satietyDownload PDF